Review



apoa1  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    Santa Cruz Biotechnology apoa1
    Workflow for EV enrichment from 4 ml (A) and 0.5 ml (B). EV markers (CD63 and Syntenin-1) and plasma contaminant proteins (Albumin and <t>ApoA1(shown</t> in red)) by western blot analysis (panel C). Starting plasma volume, final volume post concentration with the centrifugal filter and gel loading volume were used to calculate the concentration factor and equivalent plasma starting amounts indicated above figure.
    Apoa1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 158 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apoa1/bio_rxiv__64898__2026__03__11__711200-113-41-42?v=Santa+Cruz+Biotechnology
    Average 95 stars, based on 158 article reviews
    apoa1 - by Bioz Stars, 2026-07
    95/100 stars

    Images

    1) Product Images from "Combining Anion Exchange and Size Exclusion Chromatography for Extracellular Vesicle Enrichment from Small Volumes of Human and Mouse Plasma for Quantitative Proteomics"

    Article Title: Combining Anion Exchange and Size Exclusion Chromatography for Extracellular Vesicle Enrichment from Small Volumes of Human and Mouse Plasma for Quantitative Proteomics

    Journal: bioRxiv

    doi: 10.64898/2026.03.11.711200

    Workflow for EV enrichment from 4 ml (A) and 0.5 ml (B). EV markers (CD63 and Syntenin-1) and plasma contaminant proteins (Albumin and ApoA1(shown in red)) by western blot analysis (panel C). Starting plasma volume, final volume post concentration with the centrifugal filter and gel loading volume were used to calculate the concentration factor and equivalent plasma starting amounts indicated above figure.
    Figure Legend Snippet: Workflow for EV enrichment from 4 ml (A) and 0.5 ml (B). EV markers (CD63 and Syntenin-1) and plasma contaminant proteins (Albumin and ApoA1(shown in red)) by western blot analysis (panel C). Starting plasma volume, final volume post concentration with the centrifugal filter and gel loading volume were used to calculate the concentration factor and equivalent plasma starting amounts indicated above figure.

    Techniques Used: Clinical Proteomics, Western Blot, Concentration Assay

    SEC Void optimisation. Pooled SEC fractions 1-4 collected using a 2.7 mL void volume (1-4A) and a 2.8 mL void volume (1-4B) were prepared in triplicate from 0.5 mL plasma. Western blot analysis of contaminant proteins Albumin (green) and lipoprotein ApoA1 (red) (A) with 0.5 µl plasma included as a positive control (+). EV markers CD63 and syntenin-1 and small EV exclusion marker Calnexin (B). Samples (0.5 ml and 0.4 ml) from Experiment 3.2 included as a western blot control and 2µl platelet lysate included as a calnexin positive control (+). Electron microscopy (C) visualisation and size and concentration histogram (D) of EV representative SEC sample (Void 2.7 ml).
    Figure Legend Snippet: SEC Void optimisation. Pooled SEC fractions 1-4 collected using a 2.7 mL void volume (1-4A) and a 2.8 mL void volume (1-4B) were prepared in triplicate from 0.5 mL plasma. Western blot analysis of contaminant proteins Albumin (green) and lipoprotein ApoA1 (red) (A) with 0.5 µl plasma included as a positive control (+). EV markers CD63 and syntenin-1 and small EV exclusion marker Calnexin (B). Samples (0.5 ml and 0.4 ml) from Experiment 3.2 included as a western blot control and 2µl platelet lysate included as a calnexin positive control (+). Electron microscopy (C) visualisation and size and concentration histogram (D) of EV representative SEC sample (Void 2.7 ml).

    Techniques Used: Clinical Proteomics, Western Blot, Positive Control, Marker, Control, Electron Microscopy, Concentration Assay



    Similar Products

    apoa i  (MedChemExpress)
    94
    MedChemExpress apoa i
    Apoa I, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apoa1/pm41807467-371-4-12?v=MedChemExpress
    Average 94 stars, based on 1 article reviews
    apoa i - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    apoa1 mimetics  (Mimetics)
    86
    Mimetics apoa1 mimetics
    Apoa1 Mimetics, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apoa1/pmc13208257-15-4-5?v=Mimetics
    Average 86 stars, based on 1 article reviews
    apoa1 mimetics - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    immunosorbent assay  (R&D Systems)
    93
    R&D Systems immunosorbent assay
    Immunosorbent Assay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apoa1/pmc13069491-58-22-28?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    immunosorbent assay - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    apoa1  (Cell Signaling Technology Inc)
    86
    Cell Signaling Technology Inc apoa1
    Apoa1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apoa1/10__3390_slash_cancers18071086-71-53-54?v=Cell+Signaling+Technology+Inc
    Average 86 stars, based on 1 article reviews
    apoa1 - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    apoa1  (Santa Cruz Biotechnology)
    95
    Santa Cruz Biotechnology apoa1
    Workflow for EV enrichment from 4 ml (A) and 0.5 ml (B). EV markers (CD63 and Syntenin-1) and plasma contaminant proteins (Albumin and <t>ApoA1(shown</t> in red)) by western blot analysis (panel C). Starting plasma volume, final volume post concentration with the centrifugal filter and gel loading volume were used to calculate the concentration factor and equivalent plasma starting amounts indicated above figure.
    Apoa1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apoa1/bio_rxiv__64898__2026__03__11__711200-113-41-42?v=Santa+Cruz+Biotechnology
    Average 95 stars, based on 1 article reviews
    apoa1 - by Bioz Stars, 2026-07
    95/100 stars
    		  Buy from Supplier
    apoa1 mimetics m2 m1 macrophage repolarization  (Mimetics)
    86
    Mimetics apoa1 mimetics m2 m1 macrophage repolarization
    Workflow for EV enrichment from 4 ml (A) and 0.5 ml (B). EV markers (CD63 and Syntenin-1) and plasma contaminant proteins (Albumin and <t>ApoA1(shown</t> in red)) by western blot analysis (panel C). Starting plasma volume, final volume post concentration with the centrifugal filter and gel loading volume were used to calculate the concentration factor and equivalent plasma starting amounts indicated above figure.
    Apoa1 Mimetics M2 M1 Macrophage Repolarization, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apoa1/pmc13039540-153-0-1?v=Mimetics
    Average 86 stars, based on 1 article reviews
    apoa1 mimetics m2 m1 macrophage repolarization - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    apoa1 concentrations  (Orion Diagnostica Oy)
    86
    Orion Diagnostica Oy apoa1 concentrations
    Workflow for EV enrichment from 4 ml (A) and 0.5 ml (B). EV markers (CD63 and Syntenin-1) and plasma contaminant proteins (Albumin and <t>ApoA1(shown</t> in red)) by western blot analysis (panel C). Starting plasma volume, final volume post concentration with the centrifugal filter and gel loading volume were used to calculate the concentration factor and equivalent plasma starting amounts indicated above figure.
    Apoa1 Concentrations, supplied by Orion Diagnostica Oy, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apoa1/pm41787071-70-2-7?v=Orion+Diagnostica+Oy
    Average 86 stars, based on 1 article reviews
    apoa1 concentrations - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    rabbit polyclonal anti apoa1  (Biosynth Carbosynth)
    94
    Biosynth Carbosynth rabbit polyclonal anti apoa1
    Workflow for EV enrichment from 4 ml (A) and 0.5 ml (B). EV markers (CD63 and Syntenin-1) and plasma contaminant proteins (Albumin and <t>ApoA1(shown</t> in red)) by western blot analysis (panel C). Starting plasma volume, final volume post concentration with the centrifugal filter and gel loading volume were used to calculate the concentration factor and equivalent plasma starting amounts indicated above figure.
    Rabbit Polyclonal Anti Apoa1, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apoa1/pm41741636-538-63-66?v=Biosynth+Carbosynth
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal anti apoa1 - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Workflow for EV enrichment from 4 ml (A) and 0.5 ml (B). EV markers (CD63 and Syntenin-1) and plasma contaminant proteins (Albumin and ApoA1(shown in red)) by western blot analysis (panel C). Starting plasma volume, final volume post concentration with the centrifugal filter and gel loading volume were used to calculate the concentration factor and equivalent plasma starting amounts indicated above figure.

    Journal: bioRxiv

    Article Title: Combining Anion Exchange and Size Exclusion Chromatography for Extracellular Vesicle Enrichment from Small Volumes of Human and Mouse Plasma for Quantitative Proteomics

    doi: 10.64898/2026.03.11.711200

    Figure Lengend Snippet: Workflow for EV enrichment from 4 ml (A) and 0.5 ml (B). EV markers (CD63 and Syntenin-1) and plasma contaminant proteins (Albumin and ApoA1(shown in red)) by western blot analysis (panel C). Starting plasma volume, final volume post concentration with the centrifugal filter and gel loading volume were used to calculate the concentration factor and equivalent plasma starting amounts indicated above figure.

    Article Snippet: Membranes were blocked in 5% skim milk in PBS at room temperature for 1 hour before overnight incubation with primary antibodies Syntenin (Abcam, cat# ab133267), CD63 (Abcam, cat#ab134045), CD63 (Abcam, cat#ab8219), Albumin (Cell Signalling Technology, cat#4929S), Calnexin (Cell Signalling Technology, cat#2679S) ApoA1 (Santa Cruz, cat# SC-376818).

    Techniques: Clinical Proteomics, Western Blot, Concentration Assay

    SEC Void optimisation. Pooled SEC fractions 1-4 collected using a 2.7 mL void volume (1-4A) and a 2.8 mL void volume (1-4B) were prepared in triplicate from 0.5 mL plasma. Western blot analysis of contaminant proteins Albumin (green) and lipoprotein ApoA1 (red) (A) with 0.5 µl plasma included as a positive control (+). EV markers CD63 and syntenin-1 and small EV exclusion marker Calnexin (B). Samples (0.5 ml and 0.4 ml) from Experiment 3.2 included as a western blot control and 2µl platelet lysate included as a calnexin positive control (+). Electron microscopy (C) visualisation and size and concentration histogram (D) of EV representative SEC sample (Void 2.7 ml).

    Journal: bioRxiv

    Article Title: Combining Anion Exchange and Size Exclusion Chromatography for Extracellular Vesicle Enrichment from Small Volumes of Human and Mouse Plasma for Quantitative Proteomics

    doi: 10.64898/2026.03.11.711200

    Figure Lengend Snippet: SEC Void optimisation. Pooled SEC fractions 1-4 collected using a 2.7 mL void volume (1-4A) and a 2.8 mL void volume (1-4B) were prepared in triplicate from 0.5 mL plasma. Western blot analysis of contaminant proteins Albumin (green) and lipoprotein ApoA1 (red) (A) with 0.5 µl plasma included as a positive control (+). EV markers CD63 and syntenin-1 and small EV exclusion marker Calnexin (B). Samples (0.5 ml and 0.4 ml) from Experiment 3.2 included as a western blot control and 2µl platelet lysate included as a calnexin positive control (+). Electron microscopy (C) visualisation and size and concentration histogram (D) of EV representative SEC sample (Void 2.7 ml).

    Article Snippet: Membranes were blocked in 5% skim milk in PBS at room temperature for 1 hour before overnight incubation with primary antibodies Syntenin (Abcam, cat# ab133267), CD63 (Abcam, cat#ab134045), CD63 (Abcam, cat#ab8219), Albumin (Cell Signalling Technology, cat#4929S), Calnexin (Cell Signalling Technology, cat#2679S) ApoA1 (Santa Cruz, cat# SC-376818).

    Techniques: Clinical Proteomics, Western Blot, Positive Control, Marker, Control, Electron Microscopy, Concentration Assay